ZA932170B - Topical and transdermal delivery system utilizing submicron oil spheres - Google Patents

Topical and transdermal delivery system utilizing submicron oil spheres

Info

Publication number
ZA932170B
ZA932170B ZA932170A ZA932170A ZA932170B ZA 932170 B ZA932170 B ZA 932170B ZA 932170 A ZA932170 A ZA 932170A ZA 932170 A ZA932170 A ZA 932170A ZA 932170 B ZA932170 B ZA 932170B
Authority
ZA
South Africa
Prior art keywords
delivery system
oil spheres
topical
submicron oil
transdermal delivery
Prior art date
Application number
ZA932170A
Other languages
English (en)
Inventor
Doron Friedman
Joseph Schwartz
Haim Aviv
Original Assignee
Pharmos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmos Corp filed Critical Pharmos Corp
Publication of ZA932170B publication Critical patent/ZA932170B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/21—Emulsions characterized by droplet sizes below 1 micron
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915—Therapeutic or pharmaceutical composition
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/926—Topical chemical, e.g. cosmetic or sunscreen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA932170A 1992-03-26 1993-03-26 Topical and transdermal delivery system utilizing submicron oil spheres ZA932170B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL10138792A IL101387A (en) 1992-03-26 1992-03-26 Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets
US08/036,116 US6004566A (en) 1992-03-26 1993-03-23 Topical and transdermal delivery system utilizing submicron oil spheres

Publications (1)

Publication Number Publication Date
ZA932170B true ZA932170B (en) 1993-10-28

Family

ID=26322424

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA932170A ZA932170B (en) 1992-03-26 1993-03-26 Topical and transdermal delivery system utilizing submicron oil spheres

Country Status (12)

Country Link
US (1) US6004566A (de)
EP (1) EP0671903B1 (de)
JP (1) JP4173533B2 (de)
AT (1) ATE210425T1 (de)
AU (1) AU684460B2 (de)
CA (2) CA2132736C (de)
DE (1) DE69331335T2 (de)
DK (1) DK0671903T3 (de)
ES (1) ES2169042T3 (de)
IL (2) IL101387A (de)
WO (1) WO1993018752A1 (de)
ZA (1) ZA932170B (de)

Families Citing this family (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ260018A (en) * 1994-03-03 1995-10-26 Bomac Lab Ltd Benzimidazole compositions and anthelmintic compositions
GB9409778D0 (en) 1994-05-16 1994-07-06 Dumex Ltd As Compositions
DE4440337A1 (de) * 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
AT408067B (de) * 1995-03-17 2001-08-27 Gebro Pharma Gmbh Pharmazeutische zusammensetzung zur topischen applizierung und verfahren zu ihrer herstellung
EP0760237A1 (de) * 1995-08-30 1997-03-05 Cipla Limited Öl-in-Wasser-Mikroemulsionen
AU7689996A (en) * 1995-12-12 1997-07-03 Vesifact Ag Cortisone spray for topical administration
US6572880B2 (en) * 1996-10-24 2003-06-03 Pharmaceutical Applications Associates Llc Methods and transdermal compositions for pain relief
KR100294084B1 (ko) * 1998-06-02 2001-09-22 성재갑 비-스테로이드성소염진통제의경피흡수투여용조성물및이를포함하는경피흡수투여용제형
EP0858805A3 (de) * 1997-02-13 1998-09-02 National Research Institute of Chinese Medicine Transdermale Oxicamzubereitungen
TWI241915B (en) 1998-05-11 2005-10-21 Ciba Sc Holding Ag A method of preparing a pharmaceutical end formulation using a nanodispersion
US6946144B1 (en) * 1998-07-08 2005-09-20 Oryxe Transdermal delivery system
US7220427B2 (en) * 1998-07-08 2007-05-22 Oryxe Mixture for transdermal delivery of low and high molecular weight compounds
ES2211151T3 (es) 1998-08-19 2004-07-01 Skyepharma Canada Inc. Dispersiones acuosas inyectables de propofol.
IT1303692B1 (it) * 1998-11-03 2001-02-23 Chiesi Farma Spa Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione.
FR2785803B1 (fr) * 1998-11-17 2005-03-25 Sanofi Sa Utilisation d'une substance se liant au recepteur peripherique des benzodiazepines dans le traitement des stress cutanes
IL138616A0 (en) * 2000-09-21 2001-10-31 J P M E D Ltd Oil in glycerin emulsion
US7393548B2 (en) * 1999-03-22 2008-07-01 J.P. M.E.D. Ltd. Nano oil in glycerin emulsion
EP1169016A1 (de) * 1999-04-14 2002-01-09 The Procter & Gamble Company Durchsichtige zusammensetzung
IT1312088B1 (it) * 1999-04-21 2002-04-04 Altergon Sa Cerotto per uso topico contenente eparina e diclofenac.
US6515029B1 (en) 1999-04-23 2003-02-04 Kimberly-Clark Worldwide, Inc. Absorbent article having a hydrophilic lotionized bodyside liner
DE60012026T2 (de) * 1999-08-26 2004-12-30 Ganeden Biotech, Inc., San Diego Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien
AU7638300A (en) * 1999-10-20 2001-04-30 Vesifact Ag Microemulsion preconcentrates and microemulsions
US20030104041A1 (en) * 1999-12-16 2003-06-05 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
US6565879B1 (en) 1999-12-16 2003-05-20 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs with hydroxide-releasing agents as skin permeation enhancers
US6558695B2 (en) 1999-12-16 2003-05-06 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
US20050037073A1 (en) * 2000-01-13 2005-02-17 Alpharx Inc. Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof
FR2805761B1 (fr) * 2000-03-02 2002-08-30 Mainelab Nanocapsules lipidiques, procede de preparation et utilisation comme medicament
MXPA02009275A (es) * 2000-03-23 2004-09-06 Collaborative Technologies Inc Metodo para preparar dispersiones de alta presion/alto esfuerzo cortante que contienen ingredientes fisiologicamente activos.
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
FR2811564B1 (fr) * 2000-07-13 2002-12-27 Oreal Nanoemulsion contenant des polymeres non ioniques, et ses utilisations notamment dans les domaines cosmetique, dermatologique, pharmaceutique et/ou ophtalmologique
US6503526B1 (en) 2000-10-20 2003-01-07 Kimberly-Clark Worldwide, Inc. Absorbent articles enhancing skin barrier function
US6756520B1 (en) 2000-10-20 2004-06-29 Kimberly-Clark Worldwide, Inc. Hydrophilic compositions for use on absorbent articles to enhance skin barrier
FR2823117A1 (fr) * 2000-11-14 2002-10-11 Pharmascience Lab Composition pharmaceutique ou cosmetique ainsi que l'utilisation d'au moins un compose actif pour inhiber la migration des cellules de langerhans
US20020165286A1 (en) * 2000-12-08 2002-11-07 Hanne Hedeman Dermal anti-inflammatory composition
US20020128615A1 (en) 2000-12-22 2002-09-12 Tyrrell David John Absorbent articles with non-aqueous compositions containing anionic polymers
US7771735B2 (en) 2000-12-22 2010-08-10 Kimberly-Clark Worldwide, Inc. Absorbent articles with compositions for reducing irritation response
US6749860B2 (en) 2000-12-22 2004-06-15 Kimberly-Clark Worldwide, Inc. Absorbent articles with non-aqueous compositions containing botanicals
JP4098967B2 (ja) * 2001-04-18 2008-06-11 花王株式会社 ダイラタンシー組成物
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
AU2002316053A1 (en) 2001-05-01 2002-11-11 A.V. Topchiev Institute Of Petrochemical Synthesis Two-phase, water-absorbent bioadhesive composition
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
WO2002087645A1 (en) 2001-05-01 2002-11-07 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions
WO2002089849A1 (en) * 2001-05-07 2002-11-14 Corium International Compositions and delivery systems for administration of a local anesthetic agent
US20040265268A1 (en) * 2001-08-18 2004-12-30 Deepak Jain Compositions and methods for skin rejuvenation and repair
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
DE10164531A1 (de) * 2001-12-31 2003-07-17 Pharmatech Gmbh Zubereitung zur Oberflächenanästhesie der Haut
JP4549625B2 (ja) * 2002-01-05 2010-09-22 株式會社アモーレパシフィック 人参サポニン代謝産物を有効成分とする微細乳化粒子及びその製造方法、並びにこれを含有する皮膚老化防止用の化粧料組成物
DE10200578A1 (de) * 2002-01-09 2003-07-10 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme
US6579543B1 (en) * 2002-02-22 2003-06-17 Jackie H. McClung Composition for topical application to skin
IL157535A0 (en) * 2003-08-21 2004-03-28 Topimed Ltd Preparations for the prevention of skin atrophy
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
AU2004274000B2 (en) * 2003-09-19 2009-07-30 Drugtech Corporation Pharmaceutical delivery system
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
WO2005074894A1 (en) 2004-01-30 2005-08-18 Corium International Rapidly dissolving film for delivery of an active agent
MX2007001512A (es) 2004-08-05 2007-04-20 Corium Int Inc Composicion adhesiva.
KR100623013B1 (ko) * 2004-09-04 2006-09-19 김영대 나노에멀션, 그의 용도 및 제조방법
US20060079558A1 (en) * 2004-09-27 2006-04-13 Bridge Pharma. Inc. R-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine and other dermal anesthetics
WO2006036936A2 (en) * 2004-09-27 2006-04-06 Bridge Pharma, Inc. The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
DE102004059613A1 (de) * 2004-12-10 2006-06-14 Liedtke, Rainer K., Dr. Zusammensetzung und Methode einer topischen Therapie von Neurodermitis
US20060222687A1 (en) * 2005-04-01 2006-10-05 Carter Stephen G Topical anesthetic
CA2605341A1 (en) * 2005-05-09 2006-11-16 Drugtech Corporation Modified-release pharmaceutical compositions
US20070015691A1 (en) 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
WO2007079391A2 (en) * 2006-01-05 2007-07-12 Drugtech Corporation Drug delivery system for bioadhesion to a vulvovaginal surface
CN101374501A (zh) * 2006-01-05 2009-02-25 药物技术公司 组合物及其使用方法
US20100247653A1 (en) * 2006-04-11 2010-09-30 Hans Lautenschlager Nanoparticles containing nicotine and/or cotinine, dispersions, and use thereof
US7592458B2 (en) * 2006-07-21 2009-09-22 Wright George E Dermal anesthetic compounds and pharmaceutical compositions for inducing local anesthesia and mitigating neuropathic pain
RU2463038C2 (ru) 2006-10-17 2012-10-10 Нуво Рисерч Инк. Диклофенаковый гель
WO2008139264A2 (en) * 2006-11-27 2008-11-20 National Research Council Of Canada Soft gel formulations
WO2008070538A2 (en) 2006-12-01 2008-06-12 Anterios, Inc. Micellar nanoparticles comprising botulinum toxin
SG10201607909WA (en) 2006-12-01 2016-11-29 Anterios Inc Peptide nanoparticles and uses therefor
US9918934B2 (en) † 2006-12-12 2018-03-20 Edgar Joel Acosta-Zara Linker-based lecithin microemulsion delivery vehicles
WO2008151022A2 (en) 2007-05-31 2008-12-11 Anterios, Inc. Nucleic acid nanoparticles and uses therefor
EP2055298A1 (de) * 2007-10-30 2009-05-06 Novartis AG Topische Zusammensetzung
JP5340954B2 (ja) * 2007-11-16 2013-11-13 テクノガード株式会社 薬物含有脂肪乳剤およびその製造方法
US7943187B2 (en) * 2008-05-23 2011-05-17 Bakr Rabie Paeoniflorin preparations and uses thereof for fat reduction
FR2934954B1 (fr) 2008-08-14 2011-07-22 Commissariat Energie Atomique Emulsion fluorescente de vert d'indocyanine
FR2934953B1 (fr) 2008-08-14 2011-01-21 Commissariat Energie Atomique Nanoemulsions de nanocristaux
FR2934955B1 (fr) 2008-08-14 2011-07-08 Commissariat Energie Atomique Encapsulation d'agents therapeutiques lipophiles ou amphiphiles dans des nanoemulsions
CA2751884C (en) 2009-01-14 2018-09-25 Corium International, Inc. Transdermal administration of tamsulosin
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
SG10201401297QA (en) 2009-04-08 2014-08-28 Cadila Healthcare Ltd Stable pharmaceutical compositions of diclofenac
WO2012053010A2 (en) 2010-10-21 2012-04-26 Cadila Healthcare Limited Method for treatment of acne using pharmaceutical compositions of clindamycin
WO2012053009A2 (en) 2010-10-21 2012-04-26 Cadila Healthcare Limited Pharmaceutical compositions comprising skin whitening agents
MX2013004296A (es) 2010-10-21 2013-09-26 Cadila Healthcare Ltd Composiciones farmaceuticas topicas que contienen gotas de tamaño nanometrico para el tratamiento de soriasis.
WO2012053014A2 (en) 2010-10-21 2012-04-26 Cadila Healthcare Limited Method for treatment of acne using pharmaceutical compositions of clindamycin and adapalene
MX2013004248A (es) 2010-10-21 2013-07-22 Cadila Healthcare Ltd Composiciones farmaceuticas topicas que comprenden etodolaco.
WO2012053012A2 (en) 2010-10-21 2012-04-26 Cadila Healthcare Limited Topical pharmaceutical compositions comprising tfflocolchicoside
US9789123B2 (en) 2010-10-21 2017-10-17 Cadila Healthcare Limited Topical pharmaceutical compositions containing nanodroplets for the treatment of psoriasis
US10028972B2 (en) 2010-10-21 2018-07-24 Cadila Healthcare Limited Pharmaceutical compositions of anti-acne agents
WO2012127496A1 (en) * 2011-03-01 2012-09-27 Cadila Healthcare Limited Stable pharmaceutical compositions of lornoxicam or salts thereof
US9713590B2 (en) * 2011-07-28 2017-07-25 Cadila Healthcare Limited Method for treatment of pain and inflammation
US8936814B2 (en) * 2012-11-30 2015-01-20 Zuri A. Murrell Skin cream
WO2014106048A2 (en) 2012-12-31 2014-07-03 Jrx Biotechnology, Inc. Liquid topical pharmaceutical nano-emulsion formulations
DE102014102400A1 (de) * 2014-02-25 2015-08-27 Reinhard Caliebe Topische kosmetische oder pharmazeutische Zusammensetzung
CN106102778A (zh) * 2014-03-27 2016-11-09 宝丽制药股份有限公司 乳化剂型的组合物的制造方法
CA3050535C (en) * 2014-12-15 2021-11-09 Richard Clark Kaufman Methods of treating inflammatory disorders and global inflammation with compositions comprising phospholipid nanoparticle encapsulations of anti-inflammatory nutraceuticals
US10596117B1 (en) * 2014-12-31 2020-03-24 Eric Morrison Lipoleosomes as carriers for aromatic amide anesthetic compounds
US11007161B1 (en) 2014-12-31 2021-05-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films
KR20180053318A (ko) 2015-09-17 2018-05-21 제이알엑스 바이오테크놀로지, 인코포레이티드 피부 수화 또는 보습을 향상시키기 위한 접근법
JP6721960B2 (ja) * 2015-09-28 2020-07-15 株式会社ポーラファルマ 皮膚外用剤及びその製造方法並びに有効成分の放出性の向上方法及び放出性の評価方法
US10172838B1 (en) 2016-03-15 2019-01-08 Florida A&M University Self-emulsifying formulation of CARP-1 functional mimetics
AU2017360346B2 (en) 2016-11-21 2023-11-23 Eirion Therapeutics, Inc. Transdermal delivery of large agents
AU2021272476A1 (en) * 2020-05-13 2022-12-15 Follicle Pharma Ltd Compositions for delivery of bioactive agents into hair follicles
FR3120787B1 (fr) * 2021-03-19 2024-04-26 Algotherapeutix Composition pharmaceutique topique comprenant de l’amitriptyline et une phase aqueuse alcaline
RU2765470C1 (ru) * 2021-03-23 2022-01-31 Иршад Султанович Шарафутдинов Антибактериальное средство в форме геля на основе гентамицина и производного 2(5н)-фуранона

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7713618L (sv) * 1977-12-01 1979-06-02 Astra Laekemedel Ab Lokalanestetisk blandning
EP0014509A3 (de) * 1979-02-08 1981-02-11 THE PROCTER & GAMBLE COMPANY Zusammensetzungen zum Konditionieren der Haut
JPS57171912A (en) * 1981-04-14 1982-10-22 Sumitomo Chem Co Ltd Cream
FR2520253A1 (fr) * 1982-01-28 1983-07-29 Oreal Nouveau systeme emulsionnant a base d'un condensat de proteines, d'un sterol polyoxyethylene et de phosphatide et son utilisation en cosmetique
US4613330A (en) * 1982-11-26 1986-09-23 Michelson Paul E Delivery system for desired agents
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
JPH0647533B2 (ja) * 1984-08-10 1994-06-22 裕 水島 ４−ビフエニリル酢酸系化合物含有脂肪乳剤
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
DE68917544T2 (de) * 1988-06-20 1994-12-15 Shiseido Co Ltd Durchsichtiges Präparat.
US5039527A (en) * 1989-02-24 1991-08-13 Medicontrol Corporation Hexamethylmelamine containing parenteral emulsions
AU614465B2 (en) * 1989-04-05 1991-08-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
JPH0344322A (ja) * 1989-07-13 1991-02-26 Shiseido Co Ltd マイクロエマルション製剤及びその製造法
FR2655542B1 (fr) * 1989-12-13 1994-02-11 Oreal Composition cosmetique pour application topique contenant des huiles essentielles.
CA2052950A1 (en) * 1990-10-10 1992-04-11 David P. Evitts Aqueous ophthalmic microemulsions of tepoxalin
AU658608B2 (en) * 1991-03-25 1995-04-27 Astellas Pharma Europe B.V. Topical preparation containing a suspension of solid lipid particles
CA2130357A1 (en) * 1992-02-18 1993-08-19 Doron Friedman Dry compositions for preparing submicron emulsions
IL101241A (en) * 1992-03-16 1997-11-20 Yissum Res Dev Co Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier

Also Published As

Publication number Publication date
IL129921A0 (en) 2000-02-29
EP0671903A1 (de) 1995-09-20
IL129921A (en) 2004-09-27
JP4173533B2 (ja) 2008-10-29
IL101387A (en) 1999-11-30
DE69331335D1 (de) 2002-01-24
DE69331335T2 (de) 2002-08-08
EP0671903B1 (de) 2001-12-12
DK0671903T3 (da) 2002-04-15
CA2590810A1 (en) 1993-09-30
JPH07505368A (ja) 1995-06-15
ES2169042T3 (es) 2002-07-01
CA2132736C (en) 2007-09-11
US6004566A (en) 1999-12-21
ATE210425T1 (de) 2001-12-15
CA2132736A1 (en) 1993-09-30
AU3935293A (en) 1993-10-21
AU684460B2 (en) 1997-12-18
EP0671903A4 (de) 1996-01-17
WO1993018752A1 (en) 1993-09-30
IL101387A0 (en) 1992-11-15

Similar Documents

Publication Publication Date Title
ZA932170B (en) Topical and transdermal delivery system utilizing submicron oil spheres
NO931766L (no) Topiske preparater for transdermal avlevering av forloeperlegemiddelderivater av morfin
NO944957L (no) Galenisk blanding, fremgangsmåte for fremstilling av denne, samt anvendelse derav
WO1987003490A3 (en) Transdermal delivery system
ATE83653T1 (de) Hautwirksame pharmaka mit liposomen als wirkstofftraeger.
EP0979654A4 (de) Emulsionsformige aktivierte vitamin-d3 enthaltende lotione
CA2309688A1 (en) Penetration enhancing and irritation reducing systems
DE69301920T2 (de) Arzneimittel zur transmucosalen verabreichung von peptiden
US8062648B2 (en) Formulations containing melatonin, ginkgo biloba, and biotin
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
ATE77230T1 (de) Melatoninhaltige mittel sowie deren verwendungen.
JP2915931B2 (ja) 抗刺激性と除感作の組成物及びその使用方法
MY107420A (en) Transdermal system exhibiting graduated drug release and its use for the local or systemic administration of active substances.
EP0555309A1 (de) Topische zusammenstellung mit retinoidpenetrationsverstärker
BR9706889A (pt) Uso de extratos de ginkgo biloba para a preparação de composições farmacêuticas e processo de tratamento cosmético usando um extrato de ginkgo biloba
GEP20022751B (en) Aqueous Pharmaceutical Composition Comprising an Active Ingredient Which Is Highly Insoluble in Water
KR910021238A (ko) 켈로이드 치료제
ITRM920206A1 (it) Impiego di preparati contenenti cromo e vitamine e e c per il controllo del metabolismo glucidico e lipidico.
FR2802417B1 (fr) Preparations cosmetiques et/ou pharmaceutiques contenant au moins un extrait de brassicaceae
DE69228686D1 (de) Topisch anzuwendendes arzneimittel enthaltend penciclovir
ATE179070T1 (de) Dithranol enthaltendes arzneimittel zur topischen anwendung sowie herstellungsverfahren